Source: Annual Congress 2011 - Smoking-related disorders and smoking prevention
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Cano Montero, M. Nystedt- Düzakin, E. Piitulainen (Malmö, Sweden). Does smoking impair the quality of life of 34 year olds with alpha-1 antitrypsin deficiency?. Eur Respir J 2011; 38: Suppl. 55, 1556

Member's Comments

No comment yet.

Related content which might interest you: Survival in individuals with severe alpha 1-antitrypsin deficiency (PiZZ) in comparison to a general population with known smoking habits Source: Eur Respir J, 50 (3) 1700198; 10.1183/13993003.00198-2017 Year: 2017 Health-related quality of life in patients with alpha-1 antitrypsin deficiency Source: International Congress 2015 – New frontiers in the management of interstitial and orphan lung diseases Year: 2015 Decline in health status in alpha1 antitrypsin deficiency Source: International Congress 2017 – Current challenges in COPD evaluation Year: 2017 Quality of life in adolescents with asthma. A five year follow up Source: Annual Congress 2007 - Assessing asthma severity and control in children Year: 2007 Exacerbations and duration of smoking abstinence are associated with the annual decline in lung function in individuals with PiZZ alpha-1-antitrypsin deficiency Source: International Congress 2017 – Current challenges in COPD evaluation Year: 2017 What influences change in health status in COPD in a seven year follow-up? Source: International Congress 2015 – Respiratory disease management in primary care Year: 2015 Regular fish intake during the first year of life decreases the risk of eczema in preschool age Source: Annual Congress 2010 - Risk factors for allergic diseases in children Year: 2010 The patient perspective of alpha-1 antitrypsin deficiency: disease burden and unmet needs Source: Breathe, 17 (1) 200340; 10.1183/20734735.0340-2020 Year: 2021 Comparison of outcomes in augmentation naïve and augmented patients with alpha-1 antitrypsin deficiency related lung disease. Source: International Congress 2019 – COPD clinical studies: bronchodilators, corticosteroids and more Year: 2019 Alpha-1 antitrypsin deficiency in COPD patients: Time to count it in! Source: Virtual Congress 2020 – Pharmacological management of COPD Year: 2020 Trends in diagnosis and clinical presentation of alpha-1 antitrypsin deficiency within an Irish population Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management Year: 2012 The undiagnosed disease burden associated with alpha-1 antitrypsin deficiency genotypes Source: Eur Respir J, 56 (6) 2001441; 10.1183/13993003.01441-2020 Year: 2020 Long-term experience in the treatment of alpha 1-antitrypsin deficiency: 25 years of augmentation therapy Source: Eur Respir Rev 2015; 24: 46-51 Year: 2015 Factors associated with adherence in a population sample of 16 year old children with asthma Source: Eur Respir J 2005; 26: Suppl. 49, 488s Year: 2005 Passive and active smoking during life period of asthmatics (since mother's pregnancy until the age of 28 ) Source: Eur Respir J 2003; 22: Suppl. 45, 500s Year: 2003 Lung function at the age of 35 years in individuals with alpha-1-antitrypsin deficiency identified by neonatal screening Source: Annual Congress 2010 - The impact of genes and environment on obstructive airway diseases Year: 2010 Alpha 1 antitrypsin (A1AT) deficiency in children with asthma in Brazil Source: Eur Respir J 2003; 22: Suppl. 45, 499s Year: 2003 Diagnosing alpha-1 antitrypsin deficiency in Romania - first 1000 cases tested Source: Virtual Congress 2020 – Asthma and COPD: How genetic and environment influences its developement? Year: 2020 Relationship between atopy, asthma and alpha-1 antitrypsin deficiency Source: International Congress 2019 – Clinical aspects of airway diseases Year: 2019